Illumina Sues Ariosa Dx Alleging Infringement of NIPT Patent | GenomeWeb

NEW YORK (GenomeWeb) – Illumina announced after the close of the market on Friday that it is suing Ariosa Diagnostics for alleged patent infringement.

In the lawsuit filed in US District Court for the Northern District of California, Illumina has alleged that Ariosa is infringing US Patent No. 7,955,794, titled "Multiplex nucleic acid reactions." According to the patent abstract, the invention covers multiplexing methods for amplifying and/or genotyping samples simultaneously.

The patent was issued in June 2011 to researchers in San Diego and assigned to Illumina.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.